patient
suspect
central
nervou
system
cn
infect
rapid
accur
diagnosi
vital
determin
treatment
improv
prognosi
differenti
diagnosi
patient
includ
infecti
etiolog
virus
common
also
noninfecti
etiolog
autoimmun
diseas
nonetheless
half
case
caus
remain
unknown
identif
viru
aid
patient
manag
may
initi
specif
antivir
treatment
ceas
prevent
ineffect
antivir
antibiot
andor
immunosuppress
treatment
potenti
harm
side
effect
exampl
differenti
autoimmun
viral
origin
immun
suppress
could
lead
deleteri
outcom
caus
unidentifi
viru
last
two
decad
convent
diagnost
viral
cn
infect
shift
nonspecif
cultur
techniqu
toward
highlyspecif
viral
nucleic
acid
amplif
test
like
quantit
polymeras
chain
reaction
qpcr
detect
hostmedi
antibodi
product
viru
eg
elisa
although
latter
assay
greatli
increas
diagnost
sensit
limit
target
individu
viru
subset
relat
virus
number
virus
associ
cn
infect
current
compris
sever
discov
last
decad
consequ
comprehens
diagnost
panel
would
includ
mani
specif
test
sinc
unachiev
routin
diagnost
small
select
virus
commonli
associ
cn
infect
includ
diagnost
panel
eg
herp
simplex
viru
enterovirus
parechovirus
pathogen
usual
examin
test
later
stage
diseas
time
irrevers
patholog
could
occur
metagenom
recent
promis
develop
microbiolog
theoret
abl
detect
virus
includ
known
unexpect
novel
speci
sensit
assay
gener
determin
three
factor
concentr
virus
clinic
sampl
amount
background
compet
rna
dna
sequenc
depth
gener
metagenom
assay
poor
unabl
detect
virus
clinic
specimen
low
viral
load
rel
high
concentr
background
rna
dna
overcom
viral
metagenom
assay
enrich
viral
content
sampl
viru
discoveri
cdnaaflp
amplifi
fragment
length
polymorph
nextgener
sequenc
vidiscang
one
avail
assay
viral
metagenom
characterist
vidiscang
fragment
ds
c
dna
done
use
frequentcut
restrict
enzym
thu
differ
random
shear
random
pcr
amplif
transposonbas
shear
techniqu
use
viral
metagenom
assay
method
first
describ
discoveri
human
coronaviru
sinc
discov
detect
wide
rang
virus
variou
sampl
type
vidiscang
could
ideal
tool
broad
rang
detect
virus
cerebrospin
fluid
csf
csf
distinct
bodili
fluid
contain
rel
low
number
host
cell
even
mild
pleiocytosi
seen
viral
cn
infect
csf
far
lower
cellular
content
similar
volum
blood
respiratori
fecal
materi
low
amount
background
could
influenc
ng
result
two
way
may
decreas
nucleic
acid
extract
yield
total
nucleic
acid
content
low
may
benefici
proport
less
sequenc
space
taken
compet
background
rna
dna
consid
potenti
benefit
viral
metagenom
may
futur
viral
diagnost
enceph
determin
capabl
vidiscang
detect
virus
csf
sampl
patient
suspect
cn
infect
csf
sampl
previous
test
posit
viral
qpcr
select
two
biobank
depart
medic
microbiolog
neurolog
amsterdam
umc
locat
amc
qpcr
perform
use
realtim
viral
load
assay
abbott
molecular
abbott
park
il
usa
virus
test
inhous
qpcr
use
previous
publish
method
first
sampl
set
consist
anonym
leftov
csf
sampl
n
sent
patient
suspect
cn
infect
second
set
csf
sampl
n
select
clinic
studi
etiolog
enceph
mening
adult
patient
studi
approv
medic
ethic
committe
academ
medic
centr
amsterdam
netherland
refer
number
sampl
quantifi
viral
load
store
librari
prepar
vidiscang
vidisca
librari
prepar
perform
previous
describ
briefli
csf
sampl
centrifug
supernat
treat
dnase
thermo
fisher
scientif
waltham
usa
remov
nake
chromosom
bacteri
dna
nucleic
acid
extract
use
boom
method
follow
revers
transcript
nonribosom
random
hexam
second
strand
synthesi
dna
digest
msei
ttaa
new
england
biolab
ipswich
usa
ligat
adapt
contain
sampl
identifi
sequenc
fragment
vidisca
sampl
overdigest
fragment
reli
entir
presenc
restrict
enzym
recognit
site
durat
fragment
ligat
adaptor
lead
loss
restrict
enzym
recognit
site
ligat
adaptor
sequenc
ttat
wherea
ligat
anoth
dna
fragment
restor
allow
redigest
next
size
select
ampur
xp
bead
beckman
coulter
brea
ca
usa
perform
remov
small
dna
fragment
prior
pcr
use
adaptorann
primer
small
larg
size
select
perform
ampur
xp
bead
select
dnastrand
length
rang
nucleotid
librari
analyz
use
bioanalyz
high
sensit
kit
agil
genom
santa
clara
ca
usa
qubit
dsdna
hs
assay
kit
thermo
fisher
scientif
instrument
quantifi
dna
length
concentr
respect
seventi
sampl
librari
pool
equimolar
concentr
current
number
sampl
chosen
work
sampl
type
noncsf
total
pmol
dna
pool
clonal
amplifi
bead
use
ion
chef
system
thermo
fisher
scientif
sequenc
perform
ion
system
thermo
fisher
scientif
ion
chip
bp
read
length
million
sequenc
per
run
method
dnasefre
vidisca
librari
prepar
omit
dnase
step
vidiscang
read
minimum
length
nucleotid
translat
protein
sequenc
align
local
databas
ncbi
eukaryot
viral
ident
protein
group
download
march
use
ublast
vidisca
bioinformat
workflow
onlin
metagenom
profil
taxonom
identif
probabl
viral
read
background
sequenc
classif
probabl
viral
read
subsequ
confirm
origin
vidiscang
read
could
align
refer
sequenc
viru
nucleotid
ident
least
use
codoncod
align
version
align
manual
inspect
confirm
sampl
consid
vidiscang
posit
least
one
vidiscang
read
could
identifi
number
read
align
refer
sequenc
codoncod
align
taken
number
viral
read
per
sampl
analysi
vidiscang
perform
blind
qpcr
result
avoid
bias
analysi
statist
analys
perform
r
version
graph
plot
use
r
packag
version
fortyf
csf
sampl
patient
suspect
cn
infect
examin
sampl
test
routin
diagnost
enteroviru
human
immunodefici
viru
case
patient
seroposit
parechoviru
herpesvirus
herp
simplex
viru
varicellazost
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
herpesviru
csf
sampl
contain
either
singl
viru
n
multipl
virus
n
test
posit
n
enteroviru
n
n
vzv
n
ebv
n
cmv
n
n
detail
concern
qpcrresult
viral
load
total
sequenc
read
obtain
via
vidiscang
number
viral
sequenc
avail
supplementari
tabl
six
sampl
posit
enteroviru
eight
vidiscang
also
qpcr
posit
figur
rna
viru
concentr
vidiscang
posit
sampl
rang
rna
copiesml
rna
copiesml
median
rna
copiesml
two
sampl
posit
enteroviru
two
qpcr
miss
vidiscang
viral
load
rang
rna
copiesml
median
rna
copiesml
exclud
competit
background
nucleic
acid
virus
might
hamper
viru
detect
assess
whether
coinfect
pathogen
larg
quantiti
host
genom
background
compet
viral
sequenc
four
sampl
neg
vidiscang
profil
background
sequenc
neg
sampl
similar
posit
sampl
indic
major
sequenc
competit
present
figur
next
determin
whether
sequenc
depth
four
neg
sampl
combin
low
viral
load
may
insuffici
four
miss
sampl
fewer
sequenc
read
viral
load
copiesml
depict
lower
left
quadrant
figur
overal
quadrant
contain
nine
sampl
five
posit
four
neg
vidiscang
five
posit
sampl
one
n
two
n
read
map
detect
rna
viru
small
number
viral
read
suggest
sampl
low
viral
load
combin
low
sequenc
depth
detect
limit
vidiscang
sampl
similarli
low
viral
load
higher
sequenc
depth
upper
left
quadrant
figur
averag
viral
read
per
sampl
moreov
correl
sequenc
depth
viral
read
number
seen
sampl
rna
copiesml
rho
p
spearman
rank
correl
test
one
sampl
vidiscang
posit
herpesviru
vzv
also
qpcr
posit
concentr
dna
copiesml
among
sampl
remain
herpesviru
neg
vidiscang
posit
least
one
herpesviru
qpcr
median
rang
dna
copiesml
poor
perform
vidiscang
hypothes
librari
prepar
method
use
specif
restrict
enzym
may
hamper
herpesviru
detect
examin
number
put
vidiscang
fragment
number
uniqu
genom
fragment
theoret
detect
vidiscang
base
locat
restrict
enzym
recognit
site
result
fragment
length
human
herpesviru
genom
human
herpesvirus
genom
least
put
vidisca
fragment
tabl
comparison
enteroviru
genom
produc
nearli
equal
number
fragment
detect
high
success
rate
describ
next
hypothes
nucleas
treatment
may
hamper
detect
herpesviru
dna
dnase
treatment
done
prior
nucleic
acid
extract
remov
nake
chromosom
bacteri
dna
assum
viral
genom
dna
protect
dnase
viru
particl
howev
viral
dna
nonencapsid
also
degrad
therefor
repeat
librari
prepar
csf
sampl
without
dnase
treatment
dnasefre
vidiscang
eight
sampl
contain
sequenc
rna
viru
six
two
enteroviru
tabl
indic
background
dna
serious
hamper
detect
rna
virus
hand
detect
herpesvirus
greatli
increas
without
dnase
treatment
sampl
becam
vidiscang
posit
four
five
vzv
two
cmv
figur
viral
load
nucleasefre
vidiscang
herpesviru
posit
sampl
higher
median
neg
sampl
median
p
mann
whitney
u
test
associ
viru
load
vidiscadetect
becam
visibl
dna
copiesml
taken
threshold
sampl
posit
qpcr
dna
copiesml
also
posit
vidiscang
none
identifi
sever
coinfect
dna
virus
torqu
teno
viru
ttv
n
human
papillomaviru
hpv
n
hepat
b
viru
hbv
n
includ
routin
diagnost
csf
sampl
identifi
vidiscang
n
similar
effect
observ
herpesviru
detect
hypothes
nonherp
dna
virus
would
detect
dnasefre
condit
surprisingli
addit
nonherp
dna
virus
identifi
use
dnasefre
method
contrari
sampl
contain
nonherp
dna
virus
detect
regular
vidiscang
four
sampl
posit
exclud
dnase
treatment
figur
assess
overal
effect
dnase
treatment
determin
ratio
viral
read
adjust
sequenc
depth
two
treatment
arm
virus
identifi
vidiscang
studi
figur
herpesvirus
substanti
roughli
equal
number
viral
read
dnasefre
condit
contrast
opposit
true
nonherp
dna
rna
virus
metagenom
assay
potenti
benefit
diagnosi
cnsinfect
end
need
meet
certain
prerequisit
besid
detect
assay
fast
sensit
afford
vidiscang
uniqu
method
viral
metagenom
requir
rel
limit
sequenc
depth
allow
multiplex
reduc
cost
runtim
per
sampl
limit
sequenc
depth
multiplex
speed
may
come
expens
sensit
evalu
perform
vidiscang
clinic
csf
sampl
contain
virus
quantifi
via
convent
diagnost
qpcr
vidiscang
detect
rna
viru
medium
high
viral
load
sampl
rna
copiesml
low
viral
load
sampl
one
vidicsang
posit
sampl
rna
copiesml
demonstr
capabl
detect
even
low
load
virus
metagenom
use
detect
novel
unexpect
virus
csf
sever
studi
limit
number
studi
evalu
perform
two
studi
investig
limit
detect
use
dilut
spike
csf
one
studi
use
ribospia
pipelin
second
use
tailormad
protocol
includ
nextera
fragment
amplifi
studi
use
million
read
per
sampl
found
limit
detect
rna
copiesml
compar
vidiscang
read
use
besid
pathogen
detect
current
studi
vidiscang
abl
detect
larg
number
virus
includ
member
adenovirida
anellovirida
calicivirida
coronavirida
flavivirida
hepadnavirida
orthomyxovirida
paramyxovirida
parvovirida
peribunyavirida
picornavirida
pneumovirida
polyomavirida
retrovirida
sever
type
clinic
materi
stool
serum
plasma
respiratori
swab
thu
like
vidiscang
abl
detect
virus
famili
csf
similar
sensit
howev
current
find
indic
one
viral
famili
difficult
detect
vidiscang
name
herpesvirida
vidiscang
abl
detect
one
high
load
herpesviru
vzv
dna
copiesml
qpcr
posit
sampl
hypothes
nucleas
treatment
hinder
herpesviru
detect
omit
dnase
treatment
inde
yield
addit
sampl
posit
herpesviru
medium
high
load
herpesvirus
rna
copiesml
dnasefre
vidiscang
detect
vulner
herpesvirus
dnase
unexpect
boom
et
al
found
cmv
dna
serum
plasma
highli
fragment
suscept
dnase
similarli
perlejewski
et
al
describ
fourfold
decreas
read
use
dnase
treatment
metagenom
csf
studi
expand
knowledg
show
vulner
dnase
also
appli
herpesvirus
vulner
signifi
perform
metagenom
assay
evalu
spike
sampl
herpesviru
cultur
harvest
contain
infecti
virion
nonfrag
dna
wherea
herpesviru
cellfre
clinic
materi
noninfecti
mention
contain
highli
fragment
dna
two
studi
examin
perform
metagenom
assay
detect
herpesvirus
use
viru
cultur
harvest
found
low
limit
detect
dna
copiesml
cmv
respect
caution
taken
translat
find
clinic
set
viru
cultur
harvest
especi
herpesvirus
correct
repres
realiti
herpesvirus
larg
dna
genom
use
rollingcircl
amplif
produc
headtotail
concatam
progeni
viru
lytic
replic
phase
larg
amount
noninfect
nake
progeni
viru
releas
cell
may
enter
csf
replic
occur
cn
compart
high
genom
copi
number
gener
low
dnase
activ
csf
degrad
may
take
signific
amount
time
nake
herpesviru
dna
could
thu
persist
extens
amount
time
csf
even
local
infect
ceas
theori
persist
nake
dna
could
also
occur
dna
virus
hpv
ttv
virus
use
similar
replic
strategi
herpesvirus
detect
dna
virus
vidiscang
howev
hamper
dnase
treatment
figur
indic
viral
dna
virus
part
intact
virion
without
amplif
nucleic
acid
yield
csf
gener
low
effect
ng
librari
prepar
metagenom
reason
vidiscang
implement
amplif
step
increas
number
viral
genom
fragment
csf
previous
found
virus
concentr
copiesml
detect
sequenc
read
gener
per
sampl
nasopharyng
swab
sinc
use
number
threshold
ensur
suffici
sequenc
depth
achiev
viru
detect
current
result
suggest
threshold
may
increas
csf
rna
viru
sampl
miss
vidiscang
fewer
read
strong
correl
sequenc
depth
number
viral
read
observ
increas
sequenc
depth
could
therefor
increas
detect
low
load
rna
virus
recommend
gener
read
per
sampl
current
studi
multiplex
sampl
per
vidiscarun
uncommon
larg
number
patient
enceph
present
time
method
could
substanti
benefit
outbreak
research
set
larg
cohort
patient
screen
time
perform
vidiscang
remain
lower
qpcr
especi
detect
herpesvirus
vidiscang
replac
convent
diagnost
nonetheless
suggest
use
standard
vidiscang
includ
dnase
parallel
convent
diagnost
provid
cheap
lowinput
sensit
method
detect
known
rare
novel
virus
csf
